These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population. Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Cogen J; Emerson J; Sanders DB; Ren C; Schechter MS; Gibson RL; Morgan W; Rosenfeld M; Pediatr Pulmonol; 2015 Aug; 50(8):763-70. PubMed ID: 26061914 [TBL] [Abstract][Full Text] [Related]
5. Relationship between lung function and Modified Shuttle Test performance in adult patients with cystic fibrosis: a cross-sectional, retrospective study. Doeleman WR; Takken T; Bronsveld I; Hulzebos EH Physiotherapy; 2016 Jun; 102(2):184-8. PubMed ID: 27101722 [TBL] [Abstract][Full Text] [Related]
6. An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa. Sutharsan S; Naehrig S; Mellies U; Sieder C; Ziegler J BMC Pulm Med; 2020 Jun; 20(1):167. PubMed ID: 32532226 [TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience. Weir E; Burns PD; Devenny A; Young D; Paton JY Arch Dis Child; 2017 May; 102(5):440-444. PubMed ID: 27919886 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV Ramos KJ; Quon BS; Heltshe SL; Mayer-Hamblett N; Lease ED; Aitken ML; Weiss NS; Goss CH Chest; 2017 Jun; 151(6):1320-1328. PubMed ID: 28115168 [TBL] [Abstract][Full Text] [Related]
9. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316 [TBL] [Abstract][Full Text] [Related]
10. Variation in lung function is associated with worse clinical outcomes in cystic fibrosis. Heinzmann-Filho JP; Pinto LA; Marostica PJ; Donadio MV J Bras Pneumol; 2015; 41(6):509-15. PubMed ID: 26785959 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls. Kinghorn B; McNamara S; Genatossio A; Sullivan E; Siegel M; Bauer I; Clem C; Johnson RC; Davis M; Griffiths A; Wheeler W; Johnson K; Davis SD; Leigh MW; Rosenfeld M; Pittman J Ann Am Thorac Soc; 2020 Sep; 17(9):1085-1093. PubMed ID: 32603187 [No Abstract] [Full Text] [Related]
12. Rapid lung function decline in adults with early-stage cystic fibrosis lung disease. Dasenbrook EC; Fink AK; Schechter MS; Sanders DB; Millar SJ; Pasta DJ; Mayer-Hamblett N J Cyst Fibros; 2020 Jul; 19(4):527-533. PubMed ID: 31870629 [TBL] [Abstract][Full Text] [Related]
13. Increased rate of lung function decline in Australian adolescents with cystic fibrosis. Welsh L; Robertson CF; Ranganathan SC Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906 [TBL] [Abstract][Full Text] [Related]
14. Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression. Cohen-Cymberknoh M; Gindi Reiss B; Reiter J; Lechtzin N; Melo J; Pérez G; Blau H; Mussaffi H; Levine H; Bentur L; Gur M; Livnat G; Perez Miranda J; Polverino E; Blasi F; Aliberti S; Aviram M; Golan Tripto I; Picard E; Novoselsky M; Amsalem H; Hochner Celnikier D; Kerem E; Shteinberg M J Cyst Fibros; 2021 May; 20(3):388-394. PubMed ID: 32917549 [TBL] [Abstract][Full Text] [Related]
15. Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Ballmann M; Rabsch P; von der Hardt H Thorax; 1998 Sep; 53(9):732-7. PubMed ID: 10319054 [TBL] [Abstract][Full Text] [Related]
16. Effect of allergic bronchopulmonary aspergillosis on FEV Kaditis AG; Miligkos M; Bossi A; Colombo C; Hatziagorou E; Kashirskaya N; de Monestrol I; Thomas M; Mei-Zahav M; Chrousos G; Zolin A Arch Dis Child; 2017 Aug; 102(8):742-747. PubMed ID: 28325727 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis. Harun SN; Wainwright C; Klein K; Hennig S Paediatr Respir Rev; 2016 Sep; 20():55-66. PubMed ID: 27259460 [TBL] [Abstract][Full Text] [Related]
18. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre. da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217 [TBL] [Abstract][Full Text] [Related]
19. Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis. Com G; Carroll JL; Castro MM; Tang X; Jambhekar S; Berlinski A J Pediatr; 2014 Apr; 164(4):832-8. PubMed ID: 24418473 [TBL] [Abstract][Full Text] [Related]
20. Improvement of Pulmonary Function in Cystic Fibrosis Patients following Endoscopic Sinus Surgery. Kawai K; Dombrowski N; Sawicki GS; Adil EA Laryngoscope; 2021 Sep; 131(9):1930-1938. PubMed ID: 33538334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]